Literature DB >> 32296766

Molecular Mechanisms of Class B GPCR Activation: Insights from Adrenomedullin Receptors.

Michael L Garelja1, Maggie Au1,2, Margaret A Brimble1,2,3, Joseph J Gingell1,2, Erica R Hendrikse1, Annie Lovell1, Nicole Prodan1, Patrick M Sexton4, Andrew Siow1,3, Christopher S Walker1,2, Harriet A Watkins1,2, Geoffrey M Williams2,3, Denise Wootten4, Sung H Yang1,2, Paul W R Harris1,2,3, Debbie L Hay1,2.   

Abstract

Adrenomedullin (AM) is a 52 amino acid peptide that plays a regulatory role in the vasculature. Receptors for AM comprise the class B G protein-coupled receptor, the calcitonin-like receptor (CLR), in complex with one of three receptor activity-modifying proteins (RAMPs). The C-terminus of AM is involved in binding to the extracellular domain of the receptor, while the N-terminus is proposed to interact with the juxtamembranous portion of the receptor to activate signaling. There is currently limited information on the molecular determinants involved in AM signaling, thus we set out to define the importance of the AM N-terminus through five signaling pathways (cAMP production, ERK phosphorylation, CREB phosphorylation, Akt phosphorylation, and IP1 production). We characterized the three CLR:RAMP complexes through the five pathways, finding that each had a distinct repertoire of intracellular signaling pathways that it is able to regulate. We then performed an alanine scan of AM from residues 15-31 and found that most residues could be substituted with only small effects on signaling, and that most substitutions affected signaling through all receptors and pathways in a similar manner. We identify F18, T20, L26, and I30 as being critical for AM function, while also identifying an analogue (AM15-52 G19A) which has unique signaling properties relative to the unmodified AM. We interpret our findings in the context of new structural information, highlighting the complementary nature of structural biology and functional assays.
Copyright © 2020 American Chemical Society.

Entities:  

Year:  2020        PMID: 32296766      PMCID: PMC7155197          DOI: 10.1021/acsptsci.9b00083

Source DB:  PubMed          Journal:  ACS Pharmacol Transl Sci        ISSN: 2575-9108


  101 in total

1.  Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors.

Authors:  Alice C Holloway; Hongwei Qian; Luisa Pipolo; James Ziogas; Shin-ichiro Miura; Sadashiva Karnik; Bridget R Southwell; Michael J Lew; Walter G Thomas
Journal:  Mol Pharmacol       Date:  2002-04       Impact factor: 4.436

2.  Structure and dynamics of the active human parathyroid hormone receptor-1.

Authors:  Li-Hua Zhao; Shanshan Ma; Ieva Sutkeviciute; Dan-Dan Shen; X Edward Zhou; Parker W de Waal; Chen-Yao Li; Yanyong Kang; Lisa J Clark; Frederic G Jean-Alphonse; Alex D White; Dehua Yang; Antao Dai; Xiaoqing Cai; Jian Chen; Cong Li; Yi Jiang; Tomoyuki Watanabe; Thomas J Gardella; Karsten Melcher; Ming-Wei Wang; Jean-Pierre Vilardaga; H Eric Xu; Yan Zhang
Journal:  Science       Date:  2019-04-12       Impact factor: 47.728

3.  Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists.

Authors:  Girdhar Singh Deora; Cheng Xue Qin; Elizabeth A Vecchio; Aaron J Debono; Daniel L Priebbenow; Ryan M Brady; Julia Beveridge; Silvia C Teguh; Minh Deo; Lauren T May; Guy Krippner; Rebecca H Ritchie; Jonathan B Baell
Journal:  J Med Chem       Date:  2019-05-13       Impact factor: 7.446

4.  An adrenomedullin fragment retains the systemic vasodepressor activity of rat adrenomedullin.

Authors:  B Lin; Y Gao; J K Chang; J Heaton; A Hyman; H Lippton
Journal:  Eur J Pharmacol       Date:  1994-07-21       Impact factor: 4.432

5.  The Impact of Adrenomedullin Thr22 on Selectivity within the Calcitonin Receptor-like Receptor/Receptor Activity-Modifying Protein System.

Authors:  Jan-Patrick Fischer; Sylvia Els-Heindl; Ria Schönauer; Donald Bierer; Johannes Köbberling; Bernd Riedl; Annette G Beck-Sickinger
Journal:  ChemMedChem       Date:  2018-07-31       Impact factor: 3.466

6.  Calcitonin stimulates multiple stages of angiogenesis by directly acting on endothelial cells.

Authors:  Srinivasulu Chigurupati; Trupti Kulkarni; Shibu Thomas; Girish Shah
Journal:  Cancer Res       Date:  2005-09-15       Impact factor: 12.701

7.  Structure-function analysis of RAMP1 by alanine mutagenesis.

Authors:  John Simms; Debbie L Hay; Richard J Bailey; Galina Konycheva; Graham Bailey; Mark Wheatley; David R Poyner
Journal:  Biochemistry       Date:  2009-01-13       Impact factor: 3.162

8.  Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.

Authors:  Jason M Booe; Margaret L Warner; Amanda M Roehrkasse; Debbie L Hay; Augen A Pioszak
Journal:  Mol Pharmacol       Date:  2018-01-23       Impact factor: 4.436

9.  Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor.

Authors:  Jason M Booe; Christopher S Walker; James Barwell; Gabriel Kuteyi; John Simms; Muhammad A Jamaluddin; Margaret L Warner; Roslyn M Bill; Paul W Harris; Margaret A Brimble; David R Poyner; Debbie L Hay; Augen A Pioszak
Journal:  Mol Cell       Date:  2015-05-14       Impact factor: 17.970

10.  Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor.

Authors:  Yi-Lynn Liang; Maryam Khoshouei; Giuseppe Deganutti; Alisa Glukhova; Cassandra Koole; Thomas S Peat; Mazdak Radjainia; Jürgen M Plitzko; Wolfgang Baumeister; Laurence J Miller; Deborah L Hay; Arthur Christopoulos; Christopher A Reynolds; Denise Wootten; Patrick M Sexton
Journal:  Nature       Date:  2018-09-12       Impact factor: 49.962

View more
  8 in total

Review 1.  Mechanisms of adhesion G protein-coupled receptor activation.

Authors:  Alexander Vizurraga; Rashmi Adhikari; Jennifer Yeung; Maiya Yu; Gregory G Tall
Journal:  J Biol Chem       Date:  2020-08-06       Impact factor: 5.157

2.  Biochemical characterization of G protein coupling to calcitonin gene-related peptide and adrenomedullin receptors using a native PAGE assay.

Authors:  Amanda M Roehrkasse; Margaret L Warner; Jason M Booe; Augen A Pioszak
Journal:  J Biol Chem       Date:  2020-06-02       Impact factor: 5.157

3.  Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization.

Authors:  Jean-Olivier Zirimwabagabo; Ameera B A Jailani; Paris Avgoustou; Matthew J Tozer; Karl R Gibson; Paul A Glossop; James E J Mills; Roderick A Porter; Paul Blaney; Ning Wang; Timothy M Skerry; Gareth O Richards; Joseph P A Harrity
Journal:  J Med Chem       Date:  2021-03-05       Impact factor: 7.446

4.  Lipidated Calcitonin Gene-Related Peptide (CGRP) Peptide Antagonists Retain CGRP Receptor Activity and Attenuate CGRP Action In Vivo.

Authors:  Aqfan Jamaluddin; Chia-Lin Chuang; Elyse T Williams; Andrew Siow; Sung Hyun Yang; Paul W R Harris; Jakeb S S M Petersen; Rebekah L Bower; Shanan Chand; Margaret A Brimble; Christopher S Walker; Debbie L Hay; Kerry M Loomes
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

5.  Determining the Effects of Differential Expression of GRKs and β-arrestins on CLR-RAMP Agonist Bias.

Authors:  Abigail Pearce; Theo Redfern-Nichols; Matthew Harris; David R Poyner; Mark Wigglesworth; Graham Ladds
Journal:  Front Physiol       Date:  2022-03-29       Impact factor: 4.566

6.  Pharmacological characterisation of mouse calcitonin and calcitonin receptor-like receptors reveals differences compared with human receptors.

Authors:  Michael L Garelja; Rebekah L Bower; Margaret A Brimble; Shanan Chand; Paul W R Harris; Muhammad Aqfan Jamaluddin; Jakeb Petersen; Andrew Siow; Christopher S Walker; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2021-10-15       Impact factor: 8.739

7.  Discovery of a First-in-Class Potent Small Molecule Antagonist against the Adrenomedullin-2 Receptor.

Authors:  Paris Avgoustou; Ameera B A Jailani; Jean-Olivier Zirimwabagabo; Matthew J Tozer; Karl R Gibson; Paul A Glossop; James E J Mills; Roderick A Porter; Paul Blaney; Peter J Bungay; Ning Wang; Alice P Shaw; Kamilla J A Bigos; Joseph L Holmes; Jessica I Warrington; Timothy M Skerry; Joseph P A Harrity; Gareth O Richards
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-25

8.  CGRP, adrenomedullin and adrenomedullin 2 display endogenous GPCR agonist bias in primary human cardiovascular cells.

Authors:  Ashley J Clark; Niamh Mullooly; Dewi Safitri; Matthew Harris; Tessa de Vries; Antoinette MaassenVanDenBrink; David R Poyner; Davide Gianni; Mark Wigglesworth; Graham Ladds
Journal:  Commun Biol       Date:  2021-06-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.